Rating History for ResMed (RMD) by BofA Securities
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
10/20/2022 | Lyanne Harrison | Upgrade | Buy (Neutral) |
260.00 (245.00) |
215.30 (222.71) |
3.44% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
10/20/2022 | Lyanne Harrison | Upgrade | Buy (Neutral) |
260.00 (245.00) |
215.30 (222.71) |
3.44% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |